PubMed

Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells.

Nakayama S, Torikoshi Y, Takahashi T, Yoshida T, Sudo T, Matsushima T, Kawasaki Y, Katayama A, Gohda K, Hortobagyi GN, Noguchi S, Sakai T, Ishihara H, Ueno NT.

Breast Cancer Res. 2009;11(1):R12. Epub 2009 Feb 24.PMID: 19239702 [PubMed - indexed for MEDLINE]Related articlesFree article

Cyclin A-associated kinase activity is needed for paclitaxel sensitivity.

Takahashi T, Yamasaki F, Sudo T, Itamochi H, Adachi S, Tamamori-Adachi M, Ueno NT.

Mol Cancer Ther. 2005 Jul;4(7):1039-46.PMID: 16020661 [PubMed - indexed for MEDLINE]Related articlesFree article

Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.

Spänkuch B, Heim S, Kurunci-Csacsko E, Lindenau C, Yuan J, Kaufmann M, Strebhardt K.

Cancer Res. 2006 Jun 1;66(11):5836-46.PMID: 16740723 [PubMed - indexed for MEDLINE]Related articlesFree article

Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells.

Johnson N, Bentley J, Wang LZ, Newell DR, Robson CN, Shapiro GI, Curtin NJ.

Br J Cancer. 2010 Jan 19;102(2):342-50. Epub 2009 Dec 15.PMID: 20010939 [PubMed - indexed for MEDLINE]Related articles

In vivo establishment and characterization of a paclitaxel-resistant human ovarian cancer cell line showing enhanced growth properties and drug-resistance only in vivo.

Okugawa K, Kobayashi H, Hirakawa T, Sonoda T, Ogura T, Nakano H.

J Cancer Res Clin Oncol. 2004 Mar;130(3):178-86. Epub 2003 Dec 4.PMID: 14655049 [PubMed - indexed for MEDLINE]Related articles

Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity.

Yamasaki F, Zhang D, Bartholomeusz C, Sudo T, Hortobagyi GN, Kurisu K, Ueno NT.

Mol Cancer Ther. 2007 Aug;6(8):2168-77. Epub 2007 Aug 1.PMID: 17671085 [PubMed - indexed for MEDLINE]Related articlesFree article

Discovery and evaluation of dual CDK1 and CDK2 inhibitors.

Payton M, Chung G, Yakowec P, Wong A, Powers D, Xiong L, Zhang N, Leal J, Bush TL, Santora V, Askew B, Tasker A, Radinsky R, Kendall R, Coats S.

Cancer Res. 2006 Apr 15;66(8):4299-308.PMID: 16618755 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.

O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.

Cancer Chemother Pharmacol. 2008 Nov;62(6):1045-54. Epub 2008 Feb 27.PMID: 18301895 [PubMed - indexed for MEDLINE]Related articles

Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.

Maggiorella L, Deutsch E, Frascogna V, Chavaudra N, Jeanson L, Milliat F, Eschwege F, Bourhis J.

Cancer Res. 2003 May 15;63(10):2513-7.PMID: 12750274 [PubMed - indexed for MEDLINE]Related articlesFree article

Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint.

Sudo T, Nitta M, Saya H, Ueno NT.

Cancer Res. 2004 Apr 1;64(7):2502-8.PMID: 15059905 [PubMed - indexed for MEDLINE]Related articlesFree article

The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity.

Ali S, Heathcote DA, Kroll SH, Jogalekar AS, Scheiper B, Patel H, Brackow J, Siwicka A, Fuchter MJ, Periyasamy M, Tolhurst RS, Kanneganti SK, Snyder JP, Liotta DC, Aboagye EO, Barrett AG, Coombes RC.

Cancer Res. 2009 Aug 1;69(15):6208-15. Epub 2009 Jul 28.PMID: 19638587 [PubMed - indexed for MEDLINE]Related articles

Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.

Chen Y, Guggisberg N, Jorda M, Gonzalez-Angulo A, Hennessy B, Mills GB, Tan CK, Slingerland JM.

Clin Cancer Res. 2009 May 15;15(10):3396-405.PMID: 19451593 [PubMed - indexed for MEDLINE]Related articles

Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells.

Lanzi C, Cassinelli G, Cuccuru G, Supino R, Zuco V, Ferlini C, Scambia G, Zunino F.

Prostate. 2001 Sep 15;48(4):254-64.PMID: 11536305 [PubMed - indexed for MEDLINE]Related articles

Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity.

Henley D, Isbill M, Fernando R, Foster JS, Wimalasena J.

Cancer Chemother Pharmacol. 2007 Feb;59(2):235-49. Epub 2006 Sep 14.PMID: 16972069 [PubMed - indexed for MEDLINE]Related articles

Cell death induced by taxanes in breast cancer cells: cytochrome C is released in resistant but not in sensitive cells.

Ehrlichová M, Koc M, Truksa J, Naldová Z, Václavíková R, Kovárr J.

Anticancer Res. 2005 Nov-Dec;25(6B):4215-24.PMID: 16309219 [PubMed - indexed for MEDLINE]Related articles

Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol.

Androic I, Krämer A, Yan R, Rödel F, Gätje R, Kaufmann M, Strebhardt K, Yuan J.

BMC Cancer. 2008 Dec 29;8:391.PMID: 19113992 [PubMed - indexed for MEDLINE]Related articlesFree article

Enhanced interaction between tubulin and microtubule-associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxel.

Nishio K, Arioka H, Ishida T, Fukumoto H, Kurokawa H, Sata M, Ohata M, Saijo N.

Int J Cancer. 1995 Nov 27;63(5):688-93.PMID: 7591286 [PubMed - indexed for MEDLINE]Related articles

The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel.

Goldblatt EM, Gentry ER, Fox MJ, Gryaznov SM, Shen C, Herbert BS.

Mol Cancer Ther. 2009 Jul;8(7):2027-35. Epub 2009 Jun 9.PMID: 19509275 [PubMed - indexed for MEDLINE]Related articles

Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo.

Hseu YC, Chen SC, Chen HC, Liao JW, Yang HL.

Food Chem Toxicol. 2008 Aug;46(8):2680-8. Epub 2008 May 4.PMID: 18550246 [PubMed - indexed for MEDLINE]Related articles

Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors.

Sui M, Chen F, Chen Z, Fan W.

Int J Cancer. 2006 Aug 1;119(3):712-7.PMID: 16496381 [PubMed - indexed for MEDLINE]Related articles